After 23 years, BioEdge ceased published in May 2024. Not that there isn’t lots to report on and talk about, but our resources proved insufficient to move forward in an increasingly competitive environment. We began publication in 2001, smack in the middle of the controversy over embryonic stem cells. The mainstream media was full of news about promising new developments — based mostly on press releases from scientists working with human embryos.